XML 43 R34.htm IDEA: XBRL DOCUMENT
v3.23.1

EARNINGS (LOSS) PER SHARE (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS | The following calculates basic and diluted EPS: SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS
|  | Three Months Ended |
|  | March 31, 2022 |  |  | March 31, 2021 |
Net income (loss) |  | $ | 9,340,000 |  |  | $ | (613,926 | )
Deemed dividend |  |  | (6,930,335 | ) |  |  | - |
Net income (loss), numerator, basic computation |  |  | 2,409,665 |  |  |  | (613,926 | )
Recognition and change in fair value of warrant liabilities |  |  | (13,992,664 | ) |  |  | - |
Net income (loss), numerator, diluted computation |  | $ | (11,582,999 | ) |  | $ | (613,926 | )
Weighted average shares - denominator basic computation |  |  | 980,569 |  |  |  | 502,825 |
Effect of Series B warrant liabilities |  |  | 214,911 |  |  |  | - |
Weighted average shares, as adjusted - denominator diluted computation |  |  | 1,195,480 |  |  |  | 502,825 |
Earnings (loss) per common share - basic |  | $ | 2.46 |  |  | $ | (1.22 | )
Earnings (loss) per common share - diluted |  | $ | (9.69 | ) |  | $ | (1.22 | )
SCHEDULE OF ANTI-DILUTIVE SECURITIES IN WEIGHTED AVERAGE SHARES | Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share: SCHEDULE OF ANTI-DILUTIVE SECURITIES IN WEIGHTED AVERAGE SHARES
|  | For the Three Months Ended |
|  | March 31, 2022 |  |  | March 31, 2021 |
Shares subject to outstanding common stock options |  |  | 10,928 |  |  |  | 10,928 |
Shares subject to outstanding Series A warrants |  |  | 113,000 |  |  |  | 138,000 |
Shares subject to unvested stock awards |  |  | 661 |  |  |  | 1,200 |
Shares subject to conversion of Series B preferred stock |  |  | 147,939 |  |  |  | - |
Weighted-average anti-dilutive securities |  |  | 147,939 |  |  |  | - |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration